Osteomyelitis is an inflammation of the bone and bone marrow that occurs as a consequence of infections mainly attributed to Staphylococcus aureus. In a previous study, we found that expression of the chitinase 3-like 1 (CHI3L1) gene affected mineralization of MC3T3-E1 cells infected with S. aureus and there was increased expression of CHI3L1 in the blood of osteomyelitis patients. In the present study, to further investigate the role of CHI3L1 in osteomyelitis, we developed an S. aureus-induced murine model of the disease. We found that the expression of CHI3L1 was significantly up-regulated in femurs of mice infected with S. aureus compared with mice inoculated with a PBS control. To investigate these results further, we performed a CHI3L1 knock-down by lentivirus-mediated RNA interference in mice. Micro-computed tomography of infected femurs revealed that S. aureus triggers profound alterations in bone turnover, and femurs of CHI3L1 short hairpin RNA (shRNA-CHI3L1)-injected mice infected with S. aureus have significantly less cortical bone destruction when compared with control mice infected with S. aureus. Inhibition of CHI3L1 also decreased inflammation by reducing levels of proinflammatory cytokines and promoted the process of osteogenesis. The Notch signaling pathway has been shown to play an important role in modulating the differentiation of osteoblasts and osteoclasts. Our study showed that Notch1, Jagged1 and Hes1 expression significantly decreased in mice infected with S. aureus compared with the control, and shRNA-CHI3L1 could increase their level in S. aureus-infected mice. This research indicates that inhibition of CHI3L1 can reduce the debilitating effects of S. aureus in a murine model of osteomyelitis.
Osteomyelitis is an inflammation of the bone and bone marrow that occurs as a consequence of infections mainly attributed to Staphylococcus aureus. In a previous study, we found that expression of the chitinase 3-like 1 (CHI3L1) gene affected mineralization of MC3T3-E1 cells infected with S. aureus and there was increased expression of CHI3L1 in the blood of osteomyelitis patients. In the present study, to further investigate the role of CHI3L1 in osteomyelitis, we developed an S. aureus-induced murine model of the disease. We found that the expression of CHI3L1 was significantly up-regulated in femurs of mice infected with S. aureus compared with mice inoculated with a PBS control. To investigate these results further, we performed a CHI3L1 knock-down by lentivirus-mediated RNA interference in mice. Micro-computed tomography of infected femurs revealed that S. aureus triggers profound alterations in bone turnover, and femurs of CHI3L1 short hairpin RNA (shRNA-CHI3L1)-injected mice infected with S. aureus have significantly less cortical bone destruction when compared with control mice infected with S. aureus. Inhibition of CHI3L1 also decreased inflammation by reducing levels of proinflammatory cytokines and promoted the process of osteogenesis. The Notch signaling pathway has been shown to play an important role in modulating the differentiation of osteoblasts and osteoclasts. Our study showed that Notch1, Jagged1 and Hes1 expression significantly decreased in mice infected with S. aureus compared with the control, and shRNA-CHI3L1 could increase their level in S. aureus-infected mice. This research indicates that inhibition of CHI3L1 can reduce the debilitating effects of S. aureus in a murine model of osteomyelitis.
Introduction
Osteomyelitis, an inflammation of the bone marrow, is a secondary consequence of infection that can lead to osteonecrosis and bone destruction [1] . The causative agent for up to 80% of osteomyelitis cases is Staphylococcus aureus [2] . The remodeling of the mineralized bone matrix involves bone resorption by osteoclasts and the generation of new matrix by osteoblasts. Infection by bacterial pathogens can stimulate osteoclastogenesis, which leads to bone destruction through bone resorption [3, 4] . Staphylococcus aureus is believed to contribute to bone resorption, indirectly, through activating proinflammatory cytokines, which can enhance the resorption capacity of uninfected mature osteoclasts and attract osteoclast precursors to the infection site, and, directly, by enhancing the resorption ability of mature osteoclasts [4] .
Chitinase 3-like 1 (CHI3L1) mRNA is thought to mediate multiple signaling pathways by directly binding to 3 0 -untranslated regions. CHI3L1 -a glycoprotein secreted by articular chondrocytes, synoviocytes and macrophages -has been found at elevated levels in serum and synovial fluid of patients with inflammatory diseases and correlates with the degree of joint destruction in rheumatoid arthritis [5, 6] . In a previous study we found that CHI3L1 affected mineralization of MC3T3-E1 cells infected with S. aureus and demonstrated that miR-24 suppressed the expression [7] . Furthermore, we found that there was increased expression of CHI3L1 in the blood of osteomyelitis patients.
Reports have shown that the Notch signaling pathway plays an important role in modulating the differentiation of osteoblasts and osteoclasts [8] [9] [10] . Yorgan et al. [8] have found that inhibiting osteoblast-specific Notch2 in mice leads to increased trabecular bone mass at specific sites of the appendicular skeleton. In mammals, there are four notch receptors, Notch1-4, that span the cell membrane where they participate in cell-cell communication. The Notch pathway is activated by the binding of specific ligands, such as Jagged1, to these receptors, which are then cleaved by presenilins to release intracellular domains that enter the nucleus to activate transcription factors, such as hairy enhancer of Split1 (Hes1). Hes1 is believed to be activated by Notch1 and is thought to in turn regulate runt-related transcription factor 2 (Runx2), which plays a key role in osteogenic gene expression and osteoblast differentiation [11] .
In the present study, to investigate the role CHI3L1 played in the mechanisms of S. aureus-induced bone destruction, we developed a murine model of osteomyelitis. We assessed levels of CHI3L1 and inhibited CHI3L1 expression by lentivirus-mediated RNA interference (RNAi) in mice with S. aureus-infected femurs. The roles of proinflammatory cytokines and the Notch signaling pathway in osteogenesis were also assessed in relation to CHL13L1 expression.
Results

CHI3L1 expression was increased in the osteomyelitis murine model
Groups of mice were subjected to experimental osteomyelitis via intramedullary inoculation of either the S. aureus strain or an equivalent volume of sterile PBS. CHI3L1 mRNA levels of femurs were analyzed by quantitative real-time PCR (qRT-PCR) while protein levels were analyzed by western blotting. At 14 days post-inoculation, mRNA expression and protein levels of CHI3L1 were significantly higher (P < 0.01 vs day 0 group, Fig. 1A,B) . Immunohistochemically stained sections of femurs at 14 days postinoculation confirmed increased levels of CHI3L1 in osteoblasts and osteoclasts compared with the PBSinjected control (Fig. 1C) . Correspondingly, levels of the cytokines tumor necrosis factor a (TNF-a) and interleukin 1b (IL-1b), measured by enzyme-linked immunosorbent assay (ELISA), also increased and were the highest at day 14 and 7, respectively (P < 0.05 vs day 1 group, Fig. 1D ,E). TNF-a levels increased steadily throughout the 14 days whereas IL1b levels began to decrease after 7 days and were below day 5 levels at 14 days. Levels of TNF-a and IL-1b were significantly higher in S. aureus-infected mice compared with the PBS-inoculated mice throughout the 14 days (P < 0.01). These results confirm that an elevated immune response along with increased CHI3L1 expression accompanied establishment of osteomyelitis in S. aureus-infected mice.
CHI3L1 inhibition significantly reduces cortical bone destruction
To investigate these results further, we performed a CHI3L1 knock-down by lentivirus-mediated RNAi in mice. The increased CHI3L1 expression found in S. aureus-infected mice (P < 0.01) was not replicated in CHI3L1 short hairpin RNA (shRNA-CHI3L1)-injected mice (P < 0.01; Fig. 2A ). To examine the role of CHI3L1 in bone turnover we used micro-computed tomography (microCT) to assess bone structure in shRNA-CHI3L1-injected mice. MicroCT of infected femurs revealed that S. aureus triggers profound alterations in bone turnover (Fig. 2B ). Control mice infected with sterile PBS experience healing of the surgically induced cortical bone defect by day 14 postinfection. Femurs of shRNA-CHI3L1 mice infected with S. aureus have significantly less cortical bone destruction when compared with control mice infected with S. aureus (Fig. 2C ). Relative bone volume (BV) in S. aureus-infected shRNA-CHI3L1 mice was also greater than in mice with fully expressed CHI3L1 (P < 0.5, Fig. 2D ). The level of colony-forming units (CFU) in femurs and inflammatory factors were significantly reduced in shRNA-CHI3L1-injected mice when compared with mice with uninhibited CHI3L1 expression (P < 0.5, Fig. 2E -G). Histopathological scoring of inflammation was performed on hematoxylin and eosin (HE)-stained femur sections of S. aureus-infected mice with and without inhibition of CHI3L1 by shRNA-CHI3L1 (Fig. 3A,B) . Inflammation scoring was significantly higher in S. aureus-infected femurs than in the PBS-injected control (P < 0.01). However, less inflammation was observed in femurs with CHI3L1 inhibited than with it fully expressed (P < 0.05). These results suggest that inhibition of CHI3L1 decreased inflammation and that this decrease in the inflammatory response reduced the process of cortical bone destruction in a murine model of osteomyelitis.
CHI3L1 inhibition increased bone formation in S. aureus-infected mice
To investigate levels of bone resorption and formation, the osteoclast surface/bone surface ratio (OcS/BS) was quantified in femur sections by tartrate-resistant acid phosphatase (TRAP) staining and osteoblast surface/ bone surface ratio (ObS/BS) was quantified by alkaline phosphatase (ALP) staining ( Fig. 3C-F) . We found that the OcS/BS was significantly higher in S. aureusinfected femurs than in the control (P < 0.05) but this increase was significantly reduced when CHI3L1 was inhibited ( Fig. 3D , P < 0.05). Furthermore, the ObS/ BS was significantly lower in S. aureus-infected femurs than in the control (P < 0.01), but was increased by the inhibition of CHI3L1 (P < 0.05). Next, the expression of two specific biomarkers of osteogenesis, osteopontin (OPN) and Runx2, was analyzed as an indicator of bone formation. The western blotting results indicated that levels of both OPN and Runx2 were significantly decreased in femurs infected with S. aureus compared with the control (P < 0.01), indicative of the inhibition of bone formation in S. aureus-infected mice. Furthermore, protein expression levels of both OPN and Runx2 showed a statistically significant increase in S. aureus-infected femurs with CHI3L1 inhibition compared with the infected only mice (P < 0.05; Fig. 3G ). These results indicate partial restoration of osteogenesis in femurs of mice injected with shRNA-CHI3L1.
CHI3L1 inhibition increased Notch signaling in S. aureus-infected mice
As previously mentioned, the Notch signaling pathway is thought to play an important role in modulating the differentiation of osteoblasts and osteoclasts. Immunohistochemical staining of femur sections showed that expression of Notch1 decreased with S. aureus infection compared with the PBS control and inhibition of CHI3L1 by shRNA-CHI3L1 could increase Notch1 expression in S. aureus-infected femurs of mice (Fig. 4A) . Western blot analysis revealed that Notch1, Jagged1 and Hes1 levels significantly decreased in the femurs of mice infected with S. aureus compared with sterile PBS femurs (P < 0.01), and injection of shRNA-CHI3L1 could increase the levels of Notch1, Jagged1 and Hes1 in S. aureus-infected femurs (P < 0.05; Fig. 4B ). These results indicate that differentiation of osteoblasts and osteoclasts corresponded to levels of proteins involved in the Notch signaling pathway. Inhibition of CHI3L1 could increase Notch signaling in a murine model of osteomyelitis and thereby increase the ratio of osteoblasts to reduce levels of bone resorption.
Discussion
This research reveals that CHI3L1 levels and proinflammatory cytokines increase in an S. aureus murine model of osteomyelitis, while, in contrast, levels of proteins involved in Notch signaling decrease. However, we also found that inhibiting CHI3L1 with shRNA-CHI3L1 resulted in significantly less cortical bone destruction, increased expression of proteins involved in Notch signaling and a reduction in inflammation.
Recent studies implicate that chitinase-like proteins, such as CHI3L1, may play a role in inflammatory diseases [12, 13] . Furthermore, chitinases have also been associated with TNF-a in promoting osteoclastogenesis [14] . Mucci et al. [14] demonstrated that soluble factors produced by conduritol b epoxide-treated peripheral blood mononuclear cells could induce the differentiation of osteoclast precursors into mature and active osteoclasts that express chitinases and secrete proinflammatory cytokines. Other investigations revealed that expression of CHIA, CHI3L2 and CHID1 remained unchanged during osteoclast differentiation, whereas CHIT1 and CHI3L1 increased significantly and were involved in osteoclast function [15] . Di Rosa et al. [15] also discovered that inhibiting CHIT1 and CHI3L1 with small interfering RNA significantly decreased bone resorption activity. Similarly, we found that levels of CHI3L1 increased in femurs challenged with S. aureus and that this increase was also accompanied by increased levels of TNF-a and IL-1b. We also found that the level of osteoclasts increased in S. aureus-infected cells while the level of osteoblasts was significantly reduced and that this resulted in increased cortical bone destruction, whereas inhibiting CHI3L1 led to lower levels of osteoclasts with an increased ratio of osteoblasts and a reduction in bone destruction. OPN and Runx2 are specific biomarkers of osteogenesis [16] . Levels of OPN and Rnx2 were significantly decreased in femurs infected with S. aureus but with CHI3L1 inhibition these levels were increased. This demonstrates that CHI3L1 plays a role in osteogenesis but further investigations are required to fully elucidate its role in S. aureus-induced osteomyelitis. To further our understanding of the mechanisms associated with CHI3L1 in osteoclastogenesis, we examined the role played by the Notch signaling pathway. Notch signaling is believed to regulate osteoblastic and osteoclastic differentiation [9] . Altered Notch signaling can lead to a number of diseases including osteoporosis through upregulation of the pathway [17] and Alagille syndrome or spondylocostaldysostosis through downregulation [18, 19] . Deficient Notch signaling leads to an inhibition of osteoblastic commitment and low bone mass, while gain of function stimulates proliferation of immature osteoblasts resulting in increased bone density [20] . To determine if Notch signaling is influenced by CHI3L, we measured levels of Notch1, Jagged1 and Hes1 in S. aureusinfected femurs by western blotting. We found that Notch1, Jagged1 and Hes1 levels significantly decreased in the femurs of mice infected with S. aureus and that CHI3L1 inhibition could increase these levels. Furthermore, differentiation of osteoblasts and osteoclasts correlated with levels of Notch proteins. Levels of Notch proteins were significantly lower in S. aureus-infected femurs while the ratio of osteoclasts increased; in contrast, levels of Notch proteins were significantly higher in S. aureus-infected femurs when CHI3L1 was inhibited while the ratio of osteoblasts increased. This further supports the hypothesis that CHI3L1 plays a role in bone resorption and that this could be linked to the activation of inflammatory factors. Indeed, in a recent study of CHIT1 and CHI3L1 involvement in osteoarthritis, Di Rosa et al. [21] proposed that the secretion of CHIT1 and CHI3L1 could illicit an immune response through the CHI3L1-activation of TNF-a, IL1-b, vascular endothelial growth factor a, chemokine (C-C motif) ligand 2 and matrix metallopeptidase 9, which in turn prompts CHIT1 to degrade the bone matrix via its catalytic site. Our findings in an osteomyelitis model support this proposal, although the precise mechanism behind the bone absorption involving CHIT1 requires further study.
In summary, we found that expression and protein levels of CHI3L1 increased in an S. aureus-induced murine model of osteomyelitis. Elevated levels of CHI3L1 led to increased levels of proinflammatory cytokines, a reduction of Notch signaling and increased bone destruction. Inhibition of CHI3L1 by lentivirus-mediated RNAi could alleviate these responses, levels of proinflammatory cytokines were reduced, Notch signaling increased and bone destruction was less severe. These initial findings indicate that inhibition of CHI3L1 can reduce the debilitating effects of S. aureus in a murine model of osteomyelitis and may assist the development of molecular markers that will contribute to the management of the disease.
Materials and methods
Ethics statement
All animal experiments were approved by the Institutional Ethical Committee of Southwest Hospital and conformed to the National Institutes of Health guidelines on the ethical use of animals.
Bacterial strains and culture conditions
The strain used in this study was S. aureus 6850 (ATCC 53657; ATCC, Teddington, UK). For the infection experiments, S. aureus was prepared in 30 mL of brain heart infusion broth and grown in overnight cultures incubated at 37°C with 160 r.p.m. agitation. Bacteria were collected by centrifugation, washed with PBS, and resuspended to a concentration of 1 9 10 6 CFU in 2 lL PBS.
Lentivirus construction and target screening for RNAi
An RNAi target sequence was created within the mouse CHI3L1 gene along with a shRNA negative control (NC) using the following sequences: shRNA-CHI3L1, 5 0 -
RNAi sequence was inserted into a pShuttle vector and cotransduced into 293T cells to produce the lentivirus. Mice were injected intravenously via the tail vein with 100 lL lentivirus expressing CHI3L1 shRNA (shRNA-CHI3L1) or the negative control shRNA (shRNA-NC) at 2 weeks and 24 h before S. aureus or PBS inoculation. Femurs were harvested at 14 days post-inoculation for analysis.
Murine model of osteomyelitis
A murine model of osteomyelitis was created by inoculating femurs with S. aureus [22] . Before the procedure, 7-8-weeks-old C57BL/6J mice received 0.1 mgÁkg À1 buprenorphine by subcutaneous injection. Following anesthesia with isoflurane, a skin incision was made over the left hindlimb femur. The femur was then perforated using a high-speed drill with a sharp steel burr to create a 1 mm diameter hole. Staphylococcus aureus (1 9 10 6 CFU in 2 lL) or a PBS control was inoculated into the intramedullary canal through the hole. The burr hole was closed with bone wax, and the muscle and skin openings were closed by sutures. The mice recovered from anesthesia, and buprenorphine was administered postoperatively. After 14 days, the mice were euthanized and femurs were removed for either microCT analysis or CFU enumeration.
Micro-computed tomography
Micro-computed tomography assessment of excised bones was performed using procedures described previously [23, 24] . After cleaning bones of muscle and soft tissues, they were assessed on a 1076 CT scanner (SkyScan, Aartselaar, Belgium) using an X-ray source of 70 kV, 100 mA with a pixel size of 18 lm. Images were reconstructed using SkyScan Nrecon software. Regions of newly generated bone were captured with CT analyzer software. Microarchitectural parameters of the cortical bone destruction volume and the BV fraction in the region of femurs with defects were assessed.
Quantitative real-time polymerase chain reaction
Gene expression studies were carried out as described previously [25] . Briefly, the portion surrounding the drill hole was dissected from the femoral bone. After carefully separating from connective tissue the bone was crushed into powder. Total RNA was isolated from left femurs using an RNeasy Mini Kit (Qiagen, Hilden, Germany). First-strand cDNA was generated using a SuperScript VILO 
Western blotting analysis
Protein analysis was carried out on tissues isolated from the drill hole region by western blotting using a standard protocol. The tissues were directly crushed in liquid nitrogen. The protein concentration was measured with a DC protein assay kit (Bio-Rad, Hercules, CA, USA). Total proteins were separated by 10% SDS/PAGE gel and transferred onto poly(vinylidene difluoride) membranes (Immobilon-P, Millipore, Billerica, MA, USA). After blocking with 1% BSA, the membranes were incubated overnight at 4°C with one of the following primary antibodies: anti-CHI3L1 (1 : 1000; Abcam, Cambridge, MA, USA), anti-OPN (1 : 500; Abcam), anti-Runx2 (1 : 1000; Abcam), anti-Notch1 (1 : 1000; Abcam), anti-Jagged1 (1 : 500; Abcam), anti-Hes1 (1 : 500; Abcam) or anti-b-actin (1 : 2500; Abcam). After incubation with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology, Dallas, TX, USA) for 1 h at room temperature, membranes were detected using an enhanced chemiluminescence kit (Millipore). The gray values were determined by a gel image analysis system (Bio-Rad) and normalized to b-actin.
Enzyme-linked immunosorbent assays
Enzyme-linked immunosorbent assays were carried out by a protocol described previously [26] . Briefly, femurs were homogenized with 1/15 M phosphate-buffered saline (pH 7.4) and centrifuged at 1000 g, 4°C for 10 min. Levels of cytokines were measured by ELISA kits of mouse IL-1b (Genzyme, Cambridge, MA, USA) and TNF-a (Assay Designs, Inc., Ann Arbor, MI, USA) according to the manufacturers' instructions.
Histological analysis
Histological analysis was performed by a method described previously [27] . Femurs were harvested at 14 days post-inoculation and decalcified in EDTA and glycerol solution for 5-7 days at 4°C. The decalcified femurs were dehydrated and embedded in paraffin. Then 5 mm sections were cut on a rotary microtome and stained with HE, ALP, and TRAP, or for immunohistochemistry as described below.
Immunohistochemistry
Sections were processed for immunohistochemical analysis as described previously [21] . Briefly, the sections were heated (5 min 9 3) with citrate buffer (10 mM citric acid, 0.05% Tween 20, pH 6.0) in a microwave oven (750 W) to unmask antigenic sites, then blocked with 5% BSA for 1 h. Sections were then probed overnight at 4°C with the primary antibody anti-CHI3L1 (1 : 100; Abcam) or antiNotch1 (1 : 150; Abcam). They were then incubated with horseradish peroxidase-conjugated secondary antibodies and detected with peroxidase-labeled streptavidin, both incubated for 10 min at room temperature. The immunoreaction was visualized by incubating the sections for 2 min in a 0.1% 3,3 0 -diaminobenzidine and 0.02% hydrogen peroxide solution. The sections were then counterstained with Mayer's hematoxylin, observed with light microscopy and photographed.
Statistical analysis
The data are presented as the mean AE standard deviation. Statistical significance was determined using Student's t-test or one-way ANOVA followed by Dunnett's test. Analyses were performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA), and differences with P-values of <0.05 were considered significant.
